Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03067389 · ClinicalTrials.gov registry record
Combined Breast Cancer Risk Study
A clinical trial, sponsored by Myriad Genetic Laboratories.
- Completed
- Registry status
- 553
- Enrollment target
NCT03067389: Completed study, sponsored by Myriad Genetic Laboratories.
NCT03067389 is a clinical trial that has completed, run by Myriad Genetic Laboratories. The registered enrollment target is 553 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03067389 has completed, sponsored by Myriad Genetic Laboratories.
- COMPLETED
- Registry status
- 553 participants
- Enrollment target
Study Summary
A prospective, non-interventional study in women 18 to 84 years of age. Subjects will provide a sample for genetic testing and information about their medical and family history. The results of the genetic test will be combined with clinical data to validate a method of predicting breast cancer risk.
Interventions
- DIAGNOSTIC_TEST Diagnostic test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 553 participants |
| Start Date | 2016-02-06 |
| Est. Completion | 2019-01-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03067389
The ClinicalTrials.gov registry entry for NCT03067389 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 553 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Myriad Genetic Laboratories, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diagnostic test is the first listed.
NCT03067389 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03067389 about?
NCT03067389 is a clinical study titled "Combined Breast Cancer Risk Study". A prospective, non-interventional study in women 18 to 84 years of age. Subjects will provide a sample for genetic testing and information about their medical and family history. The results of the genetic test will be combined with clinical data to validate a method of predicting breast cancer risk...
What is the current status of trial NCT03067389?
This trial is currently completed. The enrollment target is 553 participants. The study started on 2016-02-06. Estimated completion is 2019-01-08.
What interventions are being tested in trial NCT03067389?
The interventions under investigation include: Diagnostic test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03067389?
This trial is sponsored by Myriad Genetic Laboratories, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.